Curocell Inc. (KOSDAQ: 372320)

South Korea flag South Korea · Delayed Price · Currency is KRW
29,250
-400 (-1.35%)
Jan 21, 2025, 3:00 PM KST
6.36%
Market Cap 413.91B
Revenue n/a
Net Income n/a
Shares Out 14.20M
EPS n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 766,170
Average Volume 153,757
Open 29,650
Previous Close 29,650
Day's Range 28,750 - 29,850
52-Week Range 19,390 - 43,000
Beta n/a
RSI 53.97
Earnings Date Apr 3, 2025

About Curocell

Curocell Inc. develops CAR-T cell therapy for the treatment of cancer. It focuses on the development of CD19 CAR-T for the treatment of lymphoma; and BCMA CAR-T for the treatment of multiple myeloma. The company was incorporated in 2016 and is based in Daejeon, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2016
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 372320
Full Company Profile

News

There is no news available yet.